0001181431-11-049439.txt : 20110915 0001181431-11-049439.hdr.sgml : 20110915 20110915163715 ACCESSION NUMBER: 0001181431-11-049439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110913 FILED AS OF DATE: 20110915 DATE AS OF CHANGE: 20110915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHESS ROBERT CENTRAL INDEX KEY: 0001227886 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 111093264 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4154825300 MAIL ADDRESS: STREET 1: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 4 1 rrd322021.xml ANNUAL DIRECTOR EQUITY COMPENSATION X0304 4 2011-09-13 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001227886 CHESS ROBERT C/O NEKTAR THERAPEUTICS 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 1 0 0 0 Stock Option 5.14 2011-09-13 4 A 0 30000 5.14 A 2019-09-12 Common Stock 30000 30000 D The Reporting Person received this equity compensation under the Amended and Restated Compensation Plan for Non-Employee Directors. 1/12th of the shares subject to the stock option shall vest per calendar month following September 30, 2011 (with all of such shares subject to the stock option becoming vested at September 30, 2012), provided that the Reporting Person continues his or her service as a director. Gil M. Labrucherie - Attorney-in-Fact 2011-09-15